ChemMedChem
Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
ChemMedChem, Volume 17, Issue 14, July 19, 2022.
ChemMedChem
The Impact of Activity‐Based Protein Profiling in Malaria Drug Discovery
ChemMedChem, Volume 17, Issue 14, July 19, 2022.
ChemMedChem
Spirooxindol‐1,3‐oxazine Alkaloids: Highly Potent and Selective Antitumor Agents Evolved from Iterative Structure Optimization
ChemMedChem, Volume 17, Issue 14, July 19, 2022.
ChemMedChem
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure‐Reactivity and Structure‐Activity Relationships
ChemMedChem, Volume 17, Issue 14, July 19, 2022.
ChemMedChem
Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6‐Dihydroindolo[2,1‐a]isoquinolines and Related Systems
ChemMedChem, Volume 17, Issue 12, June 20, 2022.